Joe Gray, Ph.D., associate director of translational research for the Knight Cancer Institute and director of the Center for Spatial Systems Biomedicine, will join Knight Cancer Institute researcher Summer Gibbs, Ph.D., assistant professor in the department of biomedical engineering, and Joseph Carroll, Ph.D., director of business development for the Knight Cancer Institute, to discuss how multi-institution, public-private partnerships are being developed and how they are advancing the research of complex biological systems.
Tuesday, Nov. 11
CLSB 3A003A/B Lecture Hall
The lecture is free and open to the public. Learn more about the lecture on Knight News.
You’re invited to the next Clinical Research Coordinator Network meeting to learn about OHSU’s research pharmacy services. CRCN’s mission is to provide ongoing education and professional development activities for clinical research personnel at OHSU and the Portland VA.
Everything you wanted to know about OHSU Research Pharmacy Services but were afraid to ask
Wednesday, Nov. 12, 2014
11 a.m to 12 p.m.
CHH 3171, room 1A
Jen Petrolati, PharmD, BCPS, OHSU pharmacist in charge, will share tips and best practices for working with research pharmacy services. Please join us to learn more about how to start, maintain, and closeout a study with research pharmacy services. Topics will include scheduling site visits, pharmacy workflow and common processes, reminders for ordering investigational products, and frequently asked questions.
This is a great opportunity to network with your peers and learn more about institutional resources. If you have any questions about the network or would like to get involved, please contact firstname.lastname@example.org or Carrie Farrar.
Just who are the scientists of OHSU? A newly released video shows us they are innovators, groundbreakers, and pioneers. They embrace an entrepreneurial spirit and work together in a state-of-the-art scientific environment. They are bold. They are creative. They care. These extraordinary individuals are the behind-the-scenes brilliance of OHSU.
In just 2 ½ minutes, the video not only shares OHSU’s scientific backstory but highlights the forward-thinking, collaborative environment that makes this a world-class place for research and discovery.
Prepare to be inspired.
A new study recently published in Nature identifies a method for site-specific gene addition that may reduce adverse effects and lead to safe and more effective gene targeting. The study, conducted by researchers at Stanford and UCSF, was performed on mice with hemophilia B and demonstrated reduced bleeding in the mice and minimal side effects typically associated with other gene addition methods.
Recent advances in imaging technology allow researchers to capture snapshots of embryonic cells as they divide and migrate through development. But capturing an image of a growing embryo every 30 seconds or so, produces terabytes of data that is time consuming to analyze. A team led by HHMI, Janelia Group Leader, Philipp Keller, Ph.D., has created a piece of software that identifies and tracks dividing cells as quickly as high-speed microscopes can collect the images. By clustering pixels and using these
clusters as the smallest unit of measurement, the researchers reduced complexity by a thousand-fold. The computer scans for connected groups of these clusters for shapes resembling nuclei and that information is then used to locate those nuclei in subsequent images.
Keller’s lab, as reported on July 20, 2014, in Nature Methods, was able to track a large fraction of early neuroblasts and could even predict the future fate and function of many cells based on their behavior.
Because Keller hopes others will use the program, which works with data from several different types of fluorescent microscopes, to advance the field of early development research, he and his team have made the software freely available on his website.
The National Institute of Neurological Disorders and Stroke are offering a 3 1/2 day course designed to introduce researchers to the principles of neurotherapeutic drug discovery and development, including the identification of a lead compound and IND enabling studies. The course will also address the unique challenges inherent in developing treatments for nervous system disorders and will address the particular challenges that academic neuroscientists are likely to face in planning and conducting drug discovery research.
February 18-21, 2015
Georgetown University Hotel & Conference Center
The course is directed by:
- Michael A. Rogawski, M.D., Ph.D., University of California Davis
- Barbara Slusher, Ph.D., M.A.S., Johns Hopkins Brain Science Institute
- Marci Glicksman, Ph.D., Brigham and Women’s Hospital and Harvard Medical School
- Karl Scheidt, Ph.D., Northwestern University
Advanced graduate students, researchers, and faculty at all levels are invited to apply. There is no tuition or registration fee, and travel expenses will be defrayed for all successful applicants. Contact Simone Upsey for more information.
The Cascade AIDS Project and OHSU, in conjunction with the 32nd Annual NHP Models for AIDS Symposium, invites teachers and community members interested in HIV/AIDS to an interactive discussion with world experts on research and care in HIV/AIDS.
The workshop, “The Latest News for HIV Vaccines, Treatments, and Possible Cures,” is free and open to the public. Speakers include
- Tyler TerMeer, executive director, Cascade AIDS Project
- Nancy Haigwood, Ph.D., AIDS vaccine researcher and director of OHSU’s Oregon National Primate Research Center
- Jonah Sacha, Ph.D., Assistant Professor at OHSU’s Vaccine & Gene Therapy Institute and ONPRC
- Hans-Peter Kiem, M.D., Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research, Fred Hutchinson Cancer Research Center
- Melissa Murphy, M.D., Associate Professor of Medicine at OHSU, and Director of the Veteran’s Administration HIV Clinic
- Julie Overbaugh, Ph.D., Fred Hutchinson Cancer Research Center
Tuesday, Nov. 11, 4 to 8 p.m. in the Gallery Room at The Nines Hotel. Register now for this event.
Check out the latest news in the office of Technology Transfer & Business Development (TTBD)
In this issue, we discuss:
- An OHSU startup company’s drug that reached FDA approval – Contrave, an anti-obesity drug that is receiving high praises
- Introducing the OHSU MedTech Alliance – A mechanism for potential investors and industry collaborators to identify OHSU medical technologies
- Learn more about industry and academic collaborations – What type of agreement is appropriate for you?
- 2014 TTBD Awards recap - Who were the special awardees at the 2014 TTBD Awards?
- News and events – Attend TTBD’s Lunch & Learn presentation, the 3rd Annual OHSU Startup Symposium, or the MedTech Alliance Launch event
View the Fall 2014 Newsletter. To be added to our distribution list, please email us at email@example.com.
If you think you have an invention or if you’d like to know more about our office, contact us at (503) 494-8200 or visit our website.
The “Dance your Ph.D.” contest challenges scientists around the world to explain their Ph.D. research without a PowerPoint or jargon–in fact, no talking at all. So if you’re tired of trying to explain what your Ph.D. research is about to friends and relatives, only to have their eyes glaze over, this contest may be for you!
Winners of the 7th annual contest sponsored by Science, AAAS (publisher of Science), and HighWire Press, were announced November 3, 2014. For winning the Biology category and overall prize, Uma Nagendra receives $1,000 and a free trip to Stanford University in May 2015, where her video will be screened. Winners in the other three categories–Physics, Chemistry, and Social Science–cover a wide range of dance. Each will receive $500.
Though this year’s contest is over, it’s never too early to start on your production for next year.
The Beckman-Argyros Award in Vision Research is intended to reward individuals who are making significant transformative breakthroughs in vision research; this may include those whose contributions to science in general, or through the development of an innovative technology or fundamental scientific breakthrough have been applied to, aided and/or improved the vision sciences. The award includes a $100,000 prize plus $400,000 over three years to support the award recipient’s research.
Limited Submission – This opportunity requires internal coordination since OHSU may only submit one application. The nominators must be holders of an established post, such as an Officer, dean or other authorized person, with signing authority, at a University, Research Institution, or an officer of a private/public corporation who has the authority to submit nomination applications on behalf of their company, and is competent, qualified and able to identify the significant transformative research of the nominee. The nominee must be a U.S. citizen or permanent resident. See sponsor announcement for complete nominee eligibility requirements.
The deadline for internal applications is November 7, 2014. If you intend to apply, complete a limited submission form before the internal deadline.